ProCE Banner Activity

Medical Minute on Key Decisions in HIV Care: Treatment Considerations for Transgender PWH

Multimedia
In this case example, learn some of the key considerations for ART management for transgender PWH including providing care within a gender-affirmative care model, considering drug-drug interactions between hormone therapy and ART, and addressing barriers to engagement and retention in care.

Released: April 18, 2022

Expiration: April 17, 2023

Share

Faculty

Michelle D. Collins-Ogle

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS

Associate Professor of Pediatrics
Division of Pediatric Infectious Diseases
Medical Director
Montefiore Adolescent and Youth Sexual-Health Clinic
Pediatric and Adolescent HIV
Children's Hospital at Montefiore
Pediatric Hospital of Albert Einstein College of Medicine
Bronx, New York

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS

Associate Professor of Pediatrics
Division of Pediatric Infectious Diseases
Medical Director
Montefiore Adolescent and Youth Sexual-Health Clinic
Pediatric and Adolescent HIV
Children's Hospital at Montefiore
Pediatric Hospital of Albert Einstein College of Medicine
Bronx, New York

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, has no relevant conflicts of interest to report.